By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

uniQure 

Meibergdreef 61

  Amsterdam  1105 BA  Netherlands
Phone: 31-20-566-7394 Fax: 31-20-566-9272


SEARCH JOBS


Industry
Pharmaceutical






Company News
uniQure (QURE) Announces Oral Presentation Of Updated Results For AMT-060 At The World Federation Of Hemophilia (WFH) 2016 World Congress 7/11/2016 12:51:10 PM
uniQure (QURE) Appoints Jonathan Garen As Chief Business Officer 7/7/2016 8:38:14 AM
Protein Sciences Corporation Announces Exclusive License To uniQure (QURE) Of Cell Line And Technology For Production Of Human Gene Therapies 6/28/2016 10:07:50 AM
uniQure (QURE) Appoints Maria E. Cantor As Senior Vice President, Investor Relations & Communications 6/27/2016 9:53:43 AM
uniQure (QURE) Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity 6/13/2016 7:46:59 AM
uniQure (QURE) Announces Results For First Quarter 2016 5/31/2016 10:32:25 AM
uniQure (QURE) Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association 5/19/2016 10:32:40 AM
uniQure (QURE) Announces Oral Presentation Of Clinical Data From Ongoing Phase I/II Study Of AMT-060 In Hemophilia B At The 21st Congress Of The European Hematology Association 5/19/2016 8:47:29 AM
uniQure (QURE) To Present At Upcoming Investor Conferences In New York City 5/12/2016 10:29:37 AM
uniQure (QURE) Announces The Nomination Of Jack Kaye To Its Board Of Directors And Proposed Corporate Governance Changes 5/10/2016 9:18:14 AM
12345678
//-->